Esophageal cancer is the 8th most common type of malignancy and the 6th most
common cause of cancer mortality in the world. Worldwide more than 400,000
patients are newly diagnosed with esophageal cancer each year. The majority of
patients (>90%) is diagnosed with the two most common histological subtypes:
squamous cell carcinoma or adenocarcinoma of the esophagus. Esophageal squamous
cell carcinoma arises from dysplastic squamous epithelium, usually as a result of
chronic irritation. Substantial alcohol intake, especially in combination with smoking,
greatly increases the risk of squamous cell carcinoma and accounts for more than 90
percent of all cases of squamous cell carcinoma of the esophagus in the developed
world. Patients with recurring symptoms of reflux have an eightfold increase in the
risk of developing esophageal adenocarcinoma. Ongoing gastroesophageal reflux
results in the replacement of normal squamous epithelium by a columnar-lined
esophagus, which is characterized by the presence of intestinal metaplasia. This
so-called Barrett’s esophagus is the precursor lesion of esophageal adenocarcinoma,
that develops through a metaplasia – dysplasia – carcinoma sequence.
http://repub.eur.nl/res/pub/22420/101201_Grotenhuis%2C%20Brechtje%20Aleid%20-%20bewerkt%20-.pdf
http://repub.eur.nl/res/pub/22420/101201_Grotenhuis%2C%20Brechtje%20Aleid%20-%20bewerkt%20-.pdf
No comments:
Post a Comment